ZA931492B - Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses - Google Patents

Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses

Info

Publication number
ZA931492B
ZA931492B ZA931492A ZA931492A ZA931492B ZA 931492 B ZA931492 B ZA 931492B ZA 931492 A ZA931492 A ZA 931492A ZA 931492 A ZA931492 A ZA 931492A ZA 931492 B ZA931492 B ZA 931492B
Authority
ZA
South Africa
Prior art keywords
antiprogestin
progestin
estrogen
kit
oral contraception
Prior art date
Application number
ZA931492A
Other languages
English (en)
Inventor
Gary D Hodgen
Krzysztof Chwalisz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA931492B publication Critical patent/ZA931492B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA931492A 1992-03-02 1993-03-02 Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses ZA931492B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84305892A 1992-03-02 1992-03-02
CN93102182A CN1090481C (zh) 1992-03-02 1993-03-02 雌激素/孕激素/抗孕激素的应用,其组合物和药盒

Publications (1)

Publication Number Publication Date
ZA931492B true ZA931492B (en) 1993-12-23

Family

ID=25743002

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931492A ZA931492B (en) 1992-03-02 1993-03-02 Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses

Country Status (16)

Country Link
US (1) US7538099B1 (de)
EP (1) EP0630246B1 (de)
JP (1) JP4152431B2 (de)
CN (1) CN1090481C (de)
AU (1) AU678150B2 (de)
BR (1) BR9306005A (de)
CZ (1) CZ291988B6 (de)
FI (1) FI110307B (de)
IL (1) IL104915A (de)
MX (1) MX9301121A (de)
NO (1) NO311327B1 (de)
NZ (1) NZ268304A (de)
PL (2) PL174785B1 (de)
SK (1) SK285963B6 (de)
WO (1) WO1993017686A1 (de)
ZA (1) ZA931492B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
DE4335876A1 (de) * 1993-10-17 1995-04-20 Schering Ag Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
DE19531936A1 (de) * 1995-08-17 1997-02-20 Schering Ag Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
TR200001334T2 (tr) 1997-11-14 2000-09-21 Akzo Nobel N.V. Progestojen-anti-progestojen rejimleri.
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
SK15502001A3 (sk) * 1999-04-29 2002-03-05 Akzo Nobel N. V. Použitie Org 33245
RU2145848C1 (ru) * 1999-07-19 2000-02-27 Авакян Гагик Норайрович Средство для лечения вторичной аменореи центрального генеза
EE200200102A (et) 1999-08-31 2003-04-15 Jenapharm Gmbh & Co. Kg Mesoprogestiinid (progesterooniretseptori modulaatorid) hormoonasendusravi (HAR) kompositsioonide komponendina
CN100581550C (zh) 2001-12-05 2010-01-20 杜拉美德药物有限公司 预防怀孕和减少经期前症状的口服避孕药
EP1624848A4 (de) 2003-05-02 2009-02-25 Duramed Pharmaceuticals Inc Verfahren zur hormonbehandlung mit kontrazeptva-schemata mit verlängertem zyklus
CN101001631B (zh) * 2003-07-16 2014-08-06 特卫华妇女健康有限公司 利用连续给予雌激素的避孕方案的激素治疗方法
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
TW200727920A (en) * 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9603856B2 (en) * 2013-11-03 2017-03-28 Flamina Holding Ag Pharmaceutical composition or group of compositions for inhibiting autocrine HCG production in adult human cells
EP3145489A1 (de) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natürliche kombinierte hormonersatzformulierungen und therapien
RU2016141135A (ru) 2014-07-29 2018-08-28 Терапьютиксмд, Инк. Трансдермальный крем
RU2017112748A (ru) 2014-11-17 2018-12-19 Арно Терапьютикс, Инк. Композиции онапристона пролонгированного действия и способы
HK1251938A1 (zh) * 2015-05-18 2019-05-03 敏捷治疗公司 避孕组合物及提高效能和调节副作用的方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CA2998924A1 (en) 2015-09-25 2017-03-30 Context Biopharma Inc. Methods of making onapristone intermediates
CA3008422A1 (en) 2015-12-15 2017-06-22 Context Biopharma Inc. Amorphous onapristone compositions and methods of making the same
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection
JP2023084729A (ja) * 2021-12-08 2023-06-20 株式会社Ihc 月経誘発キット

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890356A (en) 1973-03-26 1975-06-17 Richardson Merrell Inc 7-Alkyl-{66 {hu 3,5{b -steroids
US3928398A (en) 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents
US4416822A (en) 1982-07-09 1983-11-22 The Upjohn Company 17β-Difluoromethyl steroids
IL68222A (en) 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
ES533260A0 (es) * 1983-06-15 1985-02-01 Schering Ag Procedimiento para la preparacion de 13a-alquilgonanos
US4780461A (en) 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
AU572589B2 (en) 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
DE3702383A1 (de) 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
US5116818A (en) 1987-03-10 1992-05-26 Medical College Of Hampton Roads Method and kit for contraception with GnRH-antagonist
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
WO1993021926A1 (en) 1992-05-06 1993-11-11 Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding
US5622943A (en) 1992-05-06 1997-04-22 The Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding
US5516769A (en) 1993-02-19 1996-05-14 The Medical College Of Hampton Roads Method of inhibiting fertilization
US5468736A (en) 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
DE4344463A1 (de) 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption

Also Published As

Publication number Publication date
WO1993017686A1 (en) 1993-09-16
US7538099B1 (en) 2009-05-26
JPH07509218A (ja) 1995-10-12
CZ211194A3 (en) 1995-12-13
MX9301121A (es) 1993-09-01
EP0630246B1 (de) 2008-07-16
FI944022A0 (fi) 1994-09-01
NO943234L (no) 1994-11-01
AU3787993A (en) 1993-10-05
IL104915A0 (en) 1993-07-08
BR9306005A (pt) 1998-06-23
CZ291988B6 (cs) 2003-07-16
AU678150B2 (en) 1997-05-22
CN1079386A (zh) 1993-12-15
SK104694A3 (en) 1996-01-10
JP4152431B2 (ja) 2008-09-17
SK285963B6 (sk) 2007-12-06
FI110307B (fi) 2002-12-31
CN1090481C (zh) 2002-09-11
EP0630246A1 (de) 1994-12-28
IL104915A (en) 1998-07-15
NO311327B1 (no) 2001-11-19
NO943234D0 (no) 1994-09-01
EP0630246A4 (de) 2002-07-17
PL174785B1 (pl) 1998-09-30
PL172790B1 (pl) 1997-11-28
NZ268304A (en) 1997-02-24
FI944022L (fi) 1994-09-01

Similar Documents

Publication Publication Date Title
ZA931492B (en) Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses
HUP9602982A2 (en) Composition for contraception based on natural eostrogene
AU560487B2 (en) Contraceptive comprising gestodene and ethinylestradiol
IL115399A0 (en) A pharmaceutical composition comprising a combination of prostacyclin with an estrogen or progestin
PL340623A1 (en) Oral contraceptive agents containing antistrogen and progestin
AU8346082A (en) Methods and compositions for intravaginal contraception
AU4441993A (en) IUD inserting apparatus
HUP9904344A3 (en) Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
HUP9901662A3 (en) Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen
EP0555845A3 (en) Steroid derivatives
AU5706598A (en) Method and device for controlling mammalian reproductive cycle
AU3888697A (en) Progestin/estrogen oral contraceptive
GB9202518D0 (en) Flashing device and method for controlling charging means provided therein
AU2865295A (en) Estrogen receptor regulation and its uses
ZA933320B (en) Contraception method using competitive progesterone antagonists and novel compounds usuful therein
AU5004296A (en) Composition for oral tolerance induction and use thereof
MY110528A (en) Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses
GB9615121D0 (en) Metyhod of and means for contraception
AU1460295A (en) Method of and means for contraception
AU4439189A (en) Estrogen and progestogen containing oral dosage forms
CA2134961A1 (en) Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses
HU9600230V0 (en) Device for tearing of root
GB9402135D0 (en) Compositions for vaginal administratiom
ZA944440B (en) Novel colon-or ileum-specific steroid derivatives
AUPM997794A0 (en) Contraceptive device